[HTML][HTML] International evidence-based Kyoto guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas
T Ohtsuka, C Fernandez-del Castillo, T Furukawa… - Pancreatology, 2024 - Elsevier
This study group aimed to revise the 2017 international consensus guidelines for the
management of intraductal papillary mucinous neoplasm (IPMN) of the pancreas, and …
management of intraductal papillary mucinous neoplasm (IPMN) of the pancreas, and …
Association of high-risk stigmata and worrisome features with advanced neoplasia in intraductal papillary mucinous neoplasms (IPMN): A systematic review
Background This systematic review aimed to assess the diagnostic accuracy of the
International Consensus Fukuoka Guidelines (ICG2017) in identifying high-risk lesions of …
International Consensus Fukuoka Guidelines (ICG2017) in identifying high-risk lesions of …
Systematic review of challenging issues in pathology of intraductal papillary mucinous neoplasms
Abstract Background/Objectives: Intraductal papillary mucinous neoplasms (IPMNs) are a
cystic precursor to pancreatic cancer. IPMNs deemed clinically to be at high-risk for …
cystic precursor to pancreatic cancer. IPMNs deemed clinically to be at high-risk for …
Humoral predictors of malignancy in IPMN: a review of the literature
EC Nista, T Schepis, M Candelli, L Giuli… - International Journal of …, 2021 - mdpi.com
Pancreatic cystic lesions are increasingly detected in cross-sectional imaging. Intraductal
papillary mucinous neoplasm (IPMN) is a mucin-producing subtype of the pancreatic cyst …
papillary mucinous neoplasm (IPMN) is a mucin-producing subtype of the pancreatic cyst …
GNAS mutation detection in circulating cell-free DNA is a specific predictor for intraductal papillary mucinous neoplasms of the pancreas, especially for intestinal …
T Hata, M Mizuma, F Motoi, Y Omori, M Ishida… - Scientific reports, 2020 - nature.com
Pancreatic cystic neoplasms (PCNs) are a heterogeneous group with varying risks of
malignancy. To explore the clinical utility of liquid biopsy in cyst type classification, we …
malignancy. To explore the clinical utility of liquid biopsy in cyst type classification, we …
Clinical and molecular attributes and evaluation of pancreatic cystic neoplasm
Intraductal papillary mucinous neoplasms (IPMNs) and mucinous cystic neoplasms (MCNs)
are all considered “Pancreatic cystic neoplasms (PCNs)” and show a varying risk of …
are all considered “Pancreatic cystic neoplasms (PCNs)” and show a varying risk of …
Increased neutrophil–lymphocyte ratio predicts recurrence in patients with well-differentiated pancreatic neuroendocrine neoplasm based on the 2017 World Health …
T Miura, H Ohtsuka, T Aoki, S Aoki, T Hata, T Takadate… - BMC surgery, 2021 - Springer
Background The prognostic values of inflammation-based markers in well-differentiated
pancreatic neuroendocrine neoplasms, diagnosed according to the new 2017 World Health …
pancreatic neuroendocrine neoplasms, diagnosed according to the new 2017 World Health …
Coagulation parameters for the differential diagnosis of pancreatic cancer in the early stage: a retrospective study
L Jiaao, G Wanli, Z Kai, G Feng, P Yunpeng - European Journal of Medical …, 2023 - Springer
Background In recent years, conventional coagulation (CC) and thromboelastography (TEG)
parameters have been reported to be closely related to the progression of pancreatic cancer …
parameters have been reported to be closely related to the progression of pancreatic cancer …
Neutrophil to lymphocyte ratio is a predictive factor of malignant potential for intraductal papillary mucinous neoplasms of the pancreas
R Ohno, R Kawamoto, M Kanamoto… - Biomarker …, 2019 - journals.sagepub.com
Intraductal papillary mucinous neoplasms (IPMNs) are cystic neoplasms with the potential
for progression to pancreatic cancer. Accurate prediction of the malignant potential is …
for progression to pancreatic cancer. Accurate prediction of the malignant potential is …
Neutrophil–lymphocyte ratio dynamics are useful for distinguishing between recurrence and pseudoprogression in high-grade gliomas
Y Huang, H Ding, Q Wu, Z Li, H Li, S Li… - Cancer management …, 2019 - Taylor & Francis
Objective Distinguishing recurrence and pseudoprogression is a major challenge in the
clinical practice of treatment for high-grade gliomas (HGGs). The neutrophil–lymphocyte …
clinical practice of treatment for high-grade gliomas (HGGs). The neutrophil–lymphocyte …